Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel combined with S-1 for locally advanced or metastatic breast cancer
ChiCTR-ONC-12002221Phase 2Completed
- Sponsor
- Oncology Department of PLA General Hospital
- Start
- Apr 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and tegafur in breast cancer, sponsored by Oncology Department of PLA General Hospital. Primary endpoint: Progression-free survival. Started Apr 2011; status: completed.
02
Drugs
docetaxeltegafur
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-ONC-12002221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002221.